Search
UT Southwestern molecular geneticist wins Hill Prize from TAMEST: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/feb-debose-boyd-wins-hill-prize.html
Russell DeBose-Boyd, Ph.D., Professor of Molecular Genetics at UT Southwestern Medical Center, has been awarded the Hill Prize in Biological Sciences from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) in recognition of his long-standing research into a key mechanism
News Releases: Newsroom - UT Southwestern, Dallas, TX
https://www.utsouthwestern.edu/newsroom/articles/
Read past stories about the extraordinary work being done and the passionate people behind it.
UT Southwestern molecular biologist to receive O'Donnell Award from TAMEST: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2024/jan-tamest-tagliabracci.html
Vincent Tagliabracci, Ph.D., Associate Professor of Molecular Biology at UT Southwestern Medical Center, will receive the 2024 Edith and Peter O’Donnell Award in Biological Sciences from the Texas Academy of Medicine, Engineering, Science and Technology (TAMEST) for broadening the understanding of
New CEO to lead UTSW’s Clements University Hospital: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-cuh-ceo.html
Traci d’Auguste, M.B.A., M.S.H.A., who has more than two decades of leadership experience in academic medicine, is the new Vice President and Chief Executive Officer of UT Southwestern Medical Center’s William P. Clements Jr. University Hospital (CUH), effective today.
March of Dimes opens Texas Collaborative Prematurity Research Center: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-march-of-dimes.html
March of Dimes, a national leader in maternal and infant health research, today announced the launch of the Texas Collaborative Prematurity Research Center (PRC), uniting scientists from The University of Texas Medical Branch (UTMB) at Galveston and UT Southwestern Medical Center in Dallas.
UT Southwestern biochemist to receive O’Donnell Award from TAMEST : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/dec-nam-tamest.html
Yunsun Nam, Ph.D., Professor of Biochemistry and Biophysics at UT Southwestern Medical Center, will receive the 2026 Edith and Peter O’Donnell Award in Biological Sciences from the Texas Academy of Medicine, Engineering, Science & Technology (TAMEST) for her research into how RNAs and proteins
At 25, the Dallas Heart Study is shaping cardiac care and exploring links to brain health: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/aug-advancing-heart-health.html
Twenty-five years since its inception, the Dallas Heart Study (DHS) is recognized as one of the leading population-based studies of heart health in the U.S. It has spawned more than 230 research papers and produced major findings that have guided advancements in how cardiovascular disease
Study uncovers how biomolecular condensates cause some kidney cancers: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/june-biomolecular-kidney-cancers.html
A genetic mutation that fuses two genes drives several different cancer types by forming networks of protein interactions that alter gene expression in cells, a study by UT Southwestern Medical Center researchers suggests.
UTSW builds AI-driven system to improve data collection : Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/july-ai-model-speeds-medical-data-extraction.html
A multidisciplinary team at UT Southwestern Medical Center has developed an artificial intelligence (AI)-enabled pipeline that can quickly and accurately extract relevant information from complex, free-text medical records. The team’s novel approach, featured in npj Digital Medicine, could
Kidney cancer drug shows promise against dangerous calcium imbalance caused by tumors: Newsroom - UT Southwestern, Dallas, Texas
https://www.utsouthwestern.edu/newsroom/articles/year-2025/oct-kidney-cancer-drug.html
Elevated calcium levels in the blood – a complication of kidney cancers known as hypercalcemia – may be successfully treated with a class of medications called HIF-2 inhibitors developed by UT Southwestern Medical Center, a new study shows. The findings, published in Cancer Discovery by a team at